|
|
 |
|
Viewing report
|
|
|
|
Eisai Co Ltd Deals Briefing
Pharmalicensing Ltd., June 2006, Pages: 72
Eisai Co Ltd Deals Briefing provides an in-depth view of the 45 deals made by Eisai Co Ltd and its subsidiaries with 53 partnering companies between 2001 and 2006, in a clear and accessible PDF format.
Chapter 1: Company profile
An overview of the company, including contact details, and expertise in terms of industry sector, therapy focus and management.
Chapter 2: Financial data and deals overview
A summary of the company’s financial status and overview of the numbers of deals by deal type, therapy focus, deal stage and industry sector.
Chapter 3: Summary of deals
A comprehensive overview listing deals by partner company, subsidiary, therapy focus, development stage, deal type and industry sector with a full index of all the deals announced.
Chapter 4: List of deals
A detailed listing of all the company’s deals and alliances announced between January 2001 and March 2006.
Every deal is fully categorized, includes a detailed description, and includes financials such as headline value, upfront and milestone payments where disclosed.
Reasons to Purchase
Eisai Co Ltd Deals Briefing provides a comprehensive summary of the deals and alliances announced by the company and its subsidiaries between January 2001 and March 2006.
This report helps in:
- identifying active partners
- tracking competitor activity
- benchmarking deals
- comparing the finances of different deal types.
Eisai Co Ltd Deals Briefing brings all relevant partnering deals into one place, providing a reference to deal making by Eisai Co Ltd.
Scope of This Report
The report contains:
- a brief company profile including subsidiary names
- financial information where disclosed
- a deals overview
- specialized indexes including deals by partner company, subsidiary company, therapy focus, development stage, deal type and industry sector.
- a detailed listing of the company’s deals and alliances.
Forecasts, Projections, Market Estimates
This report provides: a financial summary table detailing the yearly total revenues, pharma revenues, R&D spend and profit of the company; and a series of tables detailing the number of deals made by deal type, by therapy focus, by development stage and by industry sector.
Who Should Buy the Report
This report is essential reading for board and executive management, and individuals in:
- business development
- licensing/partnering
- deal making
- business strategy
- marketing and promotion
- distribution and manufacturing (including contract services).
Methodology
This report is derived from data obtained from Pharmalicensing’s Partneringdesk deals and alliances database. The database is updated daily using industry sources.
Customers who bought this item also bought
PharmaVitae 2003: Eisai
Late Stage Deals: Strategy, Structure and Payment Terms
PharmaVitae 2004: Eisai Global Analysis
PharmaVitae 2004: Eisai Global & US Analysis
Cancer Diagnostic Testing World Markets
PharmaVitae 2001: Eisai
Canned Seafood in China: A Market Analysis 2005
Location Based Services (LBS)/Geographical Information Systems (GIS)�Market Research 2005
|
|
|
|
